The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dose optimization of MK-8628 (OTX015), a small molecule inhibitor of bromodomain and extra-terminal (BET) proteins, in patients (pts) with recurrent glioblastoma (GB).
 
Andreas Felix Hottinger
Research Funding - Oncoethix (Inst)
 
Marc Sanson
Research Funding - Oncoethix (Inst)
 
Elizabeth Moyal
Research Funding - Oncoethix (Inst)
 
Jean-Pierre Delord
Research Funding - Oncoethix (Inst)
 
Rita De Micheli
Research Funding - Oncoethix (Inst)
 
Keyvan Rezai
Research Funding - Oncoethix (Inst)
 
Abraham C.F. Leung
Employment - Merck
 
Susan Perez
Employment - Merck
 
Mohamed Bekradda
Employment - Oncology Therapeutic Development
Stock and Other Ownership Interests - Oncoethix
 
Nicolas Lachaux
Employment - Oncology Therapeutic Development
Stock and Other Ownership Interests - Oncoethix
 
Francois Marc Lokiec
Research Funding - Oncoethix (Inst)
 
Olivier L. Chinot
Research Funding - Oncoethix (Inst)